About Ganymed Pharmaceuticals
Ganymed Pharmaceuticals is a biopharmaceutical developing therapeutic drugs designed to kill tumor cells without harming healthy tissues.
Headquarters
Ganymed Pharmaceuticals, Mainz
Founded
2001-01-01
Industry
Biopharma, Biotechnology, Pharmaceutical
Last Funding Type
Series E
Valuation
1
Total Funding
$212.70 million dollars
IPO Status
Private
Financial
Funding Rounds
5
Number of Lead Investors
3
Total Funding Amount
$212.70 million dollars
Number of Investors
8